Throid Dysfunction in Liver Failure and Its Eddects Upon Outcome
NCT ID: NCT06179368
Last Updated: 2024-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2024-01-01
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Relationship Between Thyroid Dysfunction and Diabetes
NCT07099937
Impact of Subclinical Hypothyroidism on Liver Enzymes and Lipid Profile
NCT07236697
Hypothyroidism in Patients With Type 2 Diabetes With Early Diabetic Nephropathy
NCT03178253
Studying Thyroid Function of Haemodialysis Patients in Upper Egypt (Two Centers Study).
NCT06500663
Effects of Thyroid Hormone Enzyme Blocking on Hypothyroidism
NCT01801033
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The liver plays an important role in the metabolism of thyroid hormones, as it is the most important organ in the peripheral conversion of tetraiodothyronine (T4) to T3 by Type 1 deiodinase.
T4 and T3 regulate the basal metabolic rate of all cells, including hepatocytes, and thereby modulate hepatic function. The liver metabolizes the THS and regulates their systemic endocrine effects. Thyroid diseases may perturb liver function; liver disease modulates thyroid hormone metabolism; and a variety of systemic diseases affect both the organs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hypothroid group
throid fuction will be evaluated on admission of hepatic failure patients, and the hypothroid patients will be enroled in this group.
hypothroidism
throid fuction will be evaluated on admission of hepatic failure patients, and the hypothyroid patients will be enroled in this group.
Euthroid group
throid fuction will be evaluated on admission of hepatic failure patients, and the euothroid patients will be enroled in this group.
euothyroid
throid fuction will be evaluated on admission of hepatic failure patients, and the euothyroid patients will be enroled in this group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hypothroidism
throid fuction will be evaluated on admission of hepatic failure patients, and the hypothyroid patients will be enroled in this group.
euothyroid
throid fuction will be evaluated on admission of hepatic failure patients, and the euothyroid patients will be enroled in this group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emad Zarief , MD
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emad Zarief Kamel Said
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Punekar P, Sharma AK, Jain A. A Study of Thyroid Dysfunction in Cirrhosis of Liver and Correlation with Severity of Liver Disease. Indian J Endocrinol Metab. 2018 Sep-Oct;22(5):645-650. doi: 10.4103/ijem.IJEM_25_18.
McCormick PA. Sherlock's Diseases of the Liver and Biliary System Textbook. Hepatic Cirrhosis. In: Dooley JS, Lok AS, Burroughs AK, Heathcote EJ, editors. 12th ed. Ch. 7. UK: Wiley-Blackwell, A John Wiley and Sons, Ltd; 2011. pp. 103-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB121223
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.